Adrenomed

Inotrem

This biopharmaceutical company develops immunotherapies targeting the TREM-1 pathway for patients suffering from acute inflammatory syndromes such as septic shock.

Matisse Pharmaceuticals B.V.

This biopharmaceutical company develops heparin-derived medicinal therapies to treat sepsis and septic shock for patients in intensive care units.

Advanced Perfusion Diagnostics

This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.

AM Pharma

This biopharmaceutical company develops recombinant human alkaline phosphatase therapeutics to treat patients suffering from sepsis-associated acute kidney injury and other severe inflammatory conditions.

SepsiScan

This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.

PATH EX, Inc.

This company develops a medical device that removes bacteria and endotoxins from the bloodstream to treat sepsis patients in clinical settings.

Modus Therapeutics

This biotechnology company develops sevuparin to treat patients suffering from sepsis, septic shock, severe malaria and chronic systemic inflammation.

Adagio Therapeutics

This biopharmaceutical company develops monoclonal antibody therapies for the prevention and treatment of viral respiratory diseases, primarily serving immunocompromised patients.